Catheter-Directed Thrombolysis of Iliocaval Thrombosis in Patients With COVID-19 Infection

Mohamad Al-Otaibi; Omer Iftikhar; Yevgeniy Brailovsky; Parth Rali; Sabrina Islam; Erin Narewski; Eric Choi; Gary Cohen; Riyaz Bashir; Vladimir Lakhter

doi:10.1016/j.jaccas.2020.07.057

Catheter-Directed Thrombolysis of Iliocaval Thrombosis in Patients With COVID-19 Infection

JACC Case Rep. 2020 Oct;2(12):2016-2020. doi: 10.1016/j.jaccas.2020.07.057. Epub 2020 Aug 25.

Authors

Affiliations

¹ Department of Internal Medicine, Temple University Hospital, Philadelphia, Pennsylvania.
² Department of Interventional Cardiology, Temple University Hospital, Philadelphia, Pennsylvania.
³ Division of Cardiology, Columbia University Irving Medical Center, New York, New York.
⁴ Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, Pennsylvania.
⁵ Department of Cardiology, Temple University Hospital, Philadelphia, Pennsylvania.
⁶ Division of Vascular Surgery, Temple University Hospital, Philadelphia, Pennsylvania.
⁷ Department of Radiology, Temple University Hospital, Philadelphia, Pennsylvania.

Abstract

We present the characteristics and outcomes of the first 2 cases of catheter-directed thrombolysis performed in patients presenting with coronavirus disease-2019 (COVID-19)-related iliocaval thrombosis. (Level of Difficulty: Beginner.).

Keywords: BEC, Bashir endovascular catheter; CDT, catheter-directed thrombolysis; CFV, common femoral vein; COVID-19 infection; COVID-19 infection complication; COVID-19, coronavirus disease-2019; DVT, deep vein thrombosis; EIV, external iliac vein; IVC, inferior vena cava; LMWH, low-molecular-weight heparin; PV, popliteal vein; SARS-CoV-2, severe acute respiratory syndrome-associated coronavirus-2; clot burden; deep vein thrombosis; femoral vein thrombosis; rtPA, recombinant tissue plasminogen activator.

Publication types

Case Reports